Abstract
Protein toxins play key roles in many infectious diseases of humans which are caused by bacteria. In some cases the toxin alone is directly responsible for the majority of the symptoms of the disease (e.g. tetanus, anthrax, diphtheria). In others the toxin is one of an arsenal of virulence factors which allow the bacterium to cause disease. Antibiotics are currently the mainstay for the treatment of bacterial infections. However, increasing levels of antibiotic resistance and the indiscreet nature of antibiotic therapy are limitations. Prior to the availability of antibiotics, antisera against toxins were often used to treat bacterial disease. Nowadays, animal-sourced products, such as antisera, are generally not acceptable for use in humans. Against the background there is an increasing interest in the development of low molecular weight inhibitors of toxins for the treatment of disease. For some toxins, like anthrax toxin, botulinum toxin and shigella toxin, low molecular weight inhibitors demonstrate proof of principle of this concept. For most other toxins the design and development of inhibitors is now a very real prospect; the crystal structures of many toxins are available, and in most cases the identity of the substrate or receptor is known. This article describes in detail the rational design of bacterial toxin inhibitors.
Keywords: Antitoxin, toxin inhibitor, botulinum toxin, shiga-toxin, anthrax toxin
Current Computer-Aided Drug Design
Title: The Rational Design of Bacterial Toxin Inhibitors
Volume: 3 Issue: 1
Author(s): Graeme C. Clark, Ajit K. Basak and Richard W. Titball
Affiliation:
Keywords: Antitoxin, toxin inhibitor, botulinum toxin, shiga-toxin, anthrax toxin
Abstract: Protein toxins play key roles in many infectious diseases of humans which are caused by bacteria. In some cases the toxin alone is directly responsible for the majority of the symptoms of the disease (e.g. tetanus, anthrax, diphtheria). In others the toxin is one of an arsenal of virulence factors which allow the bacterium to cause disease. Antibiotics are currently the mainstay for the treatment of bacterial infections. However, increasing levels of antibiotic resistance and the indiscreet nature of antibiotic therapy are limitations. Prior to the availability of antibiotics, antisera against toxins were often used to treat bacterial disease. Nowadays, animal-sourced products, such as antisera, are generally not acceptable for use in humans. Against the background there is an increasing interest in the development of low molecular weight inhibitors of toxins for the treatment of disease. For some toxins, like anthrax toxin, botulinum toxin and shigella toxin, low molecular weight inhibitors demonstrate proof of principle of this concept. For most other toxins the design and development of inhibitors is now a very real prospect; the crystal structures of many toxins are available, and in most cases the identity of the substrate or receptor is known. This article describes in detail the rational design of bacterial toxin inhibitors.
Export Options
About this article
Cite this article as:
Clark C. Graeme, Basak K. Ajit and Titball W. Richard, The Rational Design of Bacterial Toxin Inhibitors, Current Computer-Aided Drug Design 2007; 3 (1) . https://dx.doi.org/10.2174/157340907780058763
| DOI https://dx.doi.org/10.2174/157340907780058763 |
Print ISSN 1573-4099 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
Call for Papers in Thematic Issues
AI in Drug Discovery
Drug discovery is traditionally a time-consuming and costly process, often taking over a decade and billions of dollars to bring a new drug to market. Recent advances in artificial intelligence (AI) have provided powerful tools to accelerate and optimize this process. AI methods, including machine learning, deep learning, and generative ...read more
Computational Design of Plant-Based Therapeutics
Plant-based therapeutics have a long history of use in traditional medicine and are gaining renewed interest due to their potential for treating various diseases, including cancer, diabetes, and neurodegenerative disorders. However, the traditional approach to plant-based drug discovery is often time-consuming and resource-intensive. Computational methods offer a powerful and efficient ...read more
Computer-aided Endoscopy and Colonoscopy Diagnostics (CAD) for Medical Instruments: Data Insights for Prediction and Classification in Medical Imaging
The increasing prevalence of gastrointestinal diseases, particularly colorectal cancer, highlights the critical role of endoscopy and colonoscopy in early detection and diagnosis. These procedures rely on the ability to interpret real-time visual and diagnostic data accurately and efficiently. However, the growing complexity of medical imaging data, coupled with the need ...read more
Deep Learning Approaches in Bioinformatics for Computer-Aided Drug Development Targeting Brain Tumors
The integration of deep learning and bioinformatics is revolutionizing the field of computer-aided drug development, particularly in the fight against brain tumors one of the most aggressive and lethal types of cancer. Brain tumors present significant challenges due to their heterogeneity and complexity, which require novel approaches for early diagnosis ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets Corrosion Protection and Self-Healing by Sol-Gel Process: A Review of Recent Patent Literature
Recent Patents on Corrosion Science Neuroprotective Effects of Citrus Fruit-Derived Flavonoids, Nobiletin and Tangeretin in Alzheimer's and Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Jembrana Disease Virus: Host Responses, Viral Dynamics and Disease Control
Current HIV Research Advances in the Management of Malignant Hemopathies: The Role of Statins
Recent Patents on DNA & Gene Sequences Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry SPED-(Styrene-Polyethyleneglycol Diacrylate-9-Decen-1-ol) - A Novel Resin for Solid Phase Peptide Synthesis; Synthesis and Characterization of Biologically Potent Endothelin Classes of Peptides
Combinatorial Chemistry & High Throughput Screening Iodinated Contrast Media in Diagnostic Imaging: Cardiovascular Side Effects
Current Pharmacogenomics and Personalized Medicine Mechanistic and Clinical Aspects of Lenalidomide Treatment for Chronic Lymphocytic Leukemia
Current Cancer Drug Targets Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin
Current Pharmaceutical Design Recent Advances in Copper Radiopharmaceuticals
Current Radiopharmaceuticals Pharmacology and Clinical Pharmacology of Methylarginines Used as Inhibitors of Nitric Oxide Synthases
Current Pharmaceutical Design TNF-Alpha Antagonism in Severe Asthma?
Recent Patents on Inflammation & Allergy Drug Discovery Molecular Modeling Studies of Estrogen Receptor Modulators
Current Computer-Aided Drug Design New Inhibitors of Glycogen Phosphorylase as Potential Antidiabetic Agents
Current Medicinal Chemistry Restoring TRAIL Induced Apoptosis Using Naturopathy. Hercules Joins Hand with Nature to Triumph Over Lernaean Hydra
Current Genomics Synthesis of β-Amino Carbonyl 6-(Aminomethyl)- and 6-(Hydroxymethyl)pyrazolopyrimidines for DPP-4 Inhibition Study
Current Medicinal Chemistry Bio-Activities and Syntheses Developments of Triptolides
Mini-Reviews in Organic Chemistry Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Identifying Novel Targets for Treatment of Liver Fibrosis: What Can We Learn from Injured Tissues which Heal Without a Scar?
Current Drug Targets





